Onward Group is proud to announce our successful achievement in assisting Dongfang Modern (DFM) acquiring 70% of Bio Health Pharmaceuticals in April this year for a total cash consideration of A$18 million.
DFM public announcement released on 20th April 2018 has stated that Onward Group was acted as financial adviser to DFM in relation to the acquisition. As a trusted legal and accounting adviser, Onward Group has played a crucial role in delivering strategic financial advisory to our client. With macro-economic analysis, tax structuring, risk assessment and due diligence, our professional team has offered tailored advice to our client, which assisted them to achieve their best financial potential.
